The invention relates to interleukin-7 (IL-7) fusion proteins, methods of their production and uses thereof. The fusion proteins comprise an immunoglobulin portion fused directly or indirectly to IL-7, which was modified at specific positions as compared to the wildtype IL-7 in order to improve biological and pharmaceutical properties. The proteins of the invention are particularly useful in treating disorders accompanied by immune deficiencies and particularly diseases which involve T-cell deficiencies.
申请公布号
WO2005063820(A2)
申请公布日期
2005.07.14
申请号
WO2004EP14555
申请日期
2004.12.21
申请人
MERCK PATENT GMBH;LAUDER, SCOTT;GILLIES, STEPHEN, D.